Low adherence to treatment in recent HIV prevention clinical trials highlights the need to better understand, measure and support product use. This study aims to develop and psychometrically evaluate tools to screen and monitor participant adherence to HIV prevention products within the context of clinical trial research. This study lays the groundwork for the development of a more integrated biomedical-behavioral approach to achieving high levels of adherence within HIV prevention trials.
Optimizing adherence in HIV prevention product trials: Development and psychometric evaluation of simple tools for screening and adherence counseling
Written By
Tolley EE, Guthrie KM, Zissette S, Fava JL, Gill K, Louw CE, Kotze P, Reddy K, MacQueen K